Retrovirology. 2009 Feb 9;6:12.

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.

van Hal SJ, Herring B, Deris Z, Wang B, Saksena NK, Dwyer DE.

Source

Centre for Infectious Diseases and Microbiology, ICPMR Westmead Hospital, University of Sydney, Westmead 2145, NSW, Australia. vanhal@gotalk.net.au

Abstract

In a recent summary of integrase sequences, primary integrase inhibitor mutations were rare. In a review of integrase inhibitor-naïve Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link with previous antiretroviral therapy, intra-subtype B divergence across the integrase gene and transmission of integrase polymorphisms were also noted. Based on these findings, we would recommend ongoing surveillance of integrase mutations, and integrase region sequencing for patients prior to commencement of integrase inhibitors.

PMID:: 19203393; [PubMed - indexed for MEDLINE]
PMCID:: PMC2649883

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance. [Antivir Ther. 2009]
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.
Tschochner M, Chopra A, Maiden TM, Ahmad IF, James I, Furrer H, Günthard HF, Mallal S, Rauch A, John M. Antivir Ther. 2009; 14(7):953-64.
Review Characterization and structural analysis of HIV-1 integrase conservation. [AIDS Rev. 2009]
Review Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF. AIDS Rev. 2009 Jan-Mar; 11(1):17-29.
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. [J Acquir Immune Defic Syndr. 2...]
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil.
Passaes CB, Guimarães ML, Fernandez SL, Lorete Rdos S, Teixeira SL, Fernandez JC, Morgado MG. J Acquir Immune Defic Syndr. 2009 May 1; 51(1):7-12.
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection. [J Antimicrob Chemother. 2010]
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C, Geretti AM, Zahonero N, Booth C, Strang A, Soriano V, De Mendoza C. J Antimicrob Chemother. 2010 Feb; 65(2):320-6. Epub 2009 Dec 9.
Review Resistance to HIV-1 integrase inhibitors: A structural perspective. [Drug Resist Updat. 2010]
Review Resistance to HIV-1 integrase inhibitors: A structural perspective.
Mouscadet JF, Delelis O, Marcelin AG, Tchertanov L. Drug Resist Updat. 2010 Aug-Oct; 13(4-5):139-50. Epub 2010 Jun 8.

See reviews... See all...

Cited by 3 PubMed Central articles

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. [Virol J. 2011]
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.
Piralla A, Paolucci S, Gulminetti R, Comolli G, Baldanti F. Virol J. 2011 Mar 31; 8:149. Epub 2011 Mar 31.
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir. [AIDS Res Hum Retroviruses. 2010]
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.
Varghese V, Liu TF, Rhee SY, Libiran P, Trevino C, Fessel WJ, Shafer RW. AIDS Res Hum Retroviruses. 2010 Dec; 26(12):1323-6. Epub 2010 Oct 21.
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors. [Antimicrob Agents Chemother. 2...]
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors.
Ceccherini-Silberstein F, Van Baelen K, Armenia D, Trignetti M, Rondelez E, Fabeni L, Scopelliti F, Pollicita M, Van Wesenbeeck L, Van Eygen V, et al. Antimicrob Agents Chemother. 2010 Sep; 54(9):3938-48. Epub 2010 May 17.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Nucleotide
Primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
PopSet
Sets of sequences from population and evolutionary genetic studies in the PopSet database reported in the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug expo...
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.
Retrovirology. 2009 Feb 9 ;6:12.

PubMed
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokin...
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion.
J Immunol. 1991 Nov 1 ;147(9):2892-901.

PubMed
Ancient, independent evolution and distinct molecular features of the novel huma...
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.
Retrovirology. 2009 Feb 2 ;6:9.

PubMed
A new class of murine leukemia virus associated with development of spontaneous ...
A new class of murine leukemia virus associated with development of spontaneous lymphomas.
Proc Natl Acad Sci U S A. 1977 Feb ;74(2):789-92.

PubMed
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola g...
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Proc Natl Acad Sci U S A. 2009 Feb 24 ;106(8):2886-91. Epub 2009 Jan 28 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: